FIELD: medicine; pharmaceutical industry. SUBSTANCE: this process includes such steps as admixing of theophylline with interpolymer complex of polymethacrylic acid and polyethyleneglycol, wetting admixture by interpolymer complex solution in phosphate buffer, alcohol or water-alkali solution at pH value of 4.5 to 7.5, subjecting resulting stock to water-stream granulation, drying this stock, and finally carrying out subsequent steps of manufacture of finished medicinal form. According to another version, tablets may be manufactured by method of briquetting. Tablets are coated with film-forming solution based on same interpolymer complex. Medicinal preparation manufactured by disclosed method is effective when administered in dose of 450 to 600 mg/24 h and maintains therapeutic concentration of theophylline in plasma by two intakes. Mean absorption time is 12 h. EFFECT: more prolonged period of maintaining of effective concentration of medicinal preparation in blood. 3 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
PROCESS FOR MANUFACTURE OF LONG-ACTING QUINIDINE SULFATE TABLETS | 1992 |
|
RU2036641C1 |
ANTIINFLAMMATORY COMPOSITION OF PROLONGED ACTION BASED ON SODIUM DICLOFENAC AND METHOD OF ITS PREPARING | 1992 |
|
RU2070034C1 |
BRONCHOLYTIC AGENT AND A METHOD OF ITS PREPARING | 1995 |
|
RU2097036C1 |
BRONCHOLITHIC PREPARATION AND METHOD FOR ITS OBTAINING | 2000 |
|
RU2203062C2 |
METHOD OF THEOPHYLLINE-BASE MEDICINAL AGENT PREPARING | 2001 |
|
RU2188639C1 |
PROLONGED PHARMACEUTICAL COMPOSITION DRUG FORM AND METHOD OF ITS PRODUCTION (VERSIONS) | 2009 |
|
RU2435584C2 |
PHARMACEUTICAL COMPOSITION USING IN PANCREAS DISEASES | 2002 |
|
RU2207847C1 |
PHARMACEUTICAL COMPOSITIONS WITH PROLONGED RELEASE FOR TREATING CEREBROVASCULAR DISORDERS | 2014 |
|
RU2611339C2 |
ANTIULCER AGENT AS TABLETS AND METHOD OF ITS PREPARING | 1996 |
|
RU2131264C1 |
PHARMACEUTICAL COMPOSITION ELICITING ANTIFUNGAL ACTIVITY AND METHOD FOR IT PREPARING | 2002 |
|
RU2205644C1 |
Authors
Dates
1995-06-09—Published
1992-05-29—Filed